Showing results (631-640 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|April 21, 2015
Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) InhibitorsKe Zheng, Chul Min Park, Sarah Iqbal, et al.ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related PainMark D Andrews, Kerry Af Forselles, Kevin Beaumont, et al.ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5Percy H Carter, Gregory D Brown, Robert J Cherney, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Radiosynthesis and Evaluation of 18F‑Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-HydroxylaseYinlong Li, Zhendong Song, Haofeng Shi, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Styrylquinoline Derivatives as IGF1R InhibitorsPatryk Zioła, Katarzyna Malarz, Marcin Pacholczyk, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC)Ram W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Synthesis and Biological Evaluation of a Novel Dual-Targeting Small Molecule Drug Conjugate Modulating the Crosstalk between α5β1 Integrin and MDM2 in GlioblastomaFederico Arrigoni, Ana Ferrari, Helena Prpić, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Design and Synthesis of Actin-Targeting 10-Phenoxy Cytochalasan Analogues: Balancing Cytotoxicity and Migrastatic ActivityŽaneta Javorská, Tereza Volfová, Johan Faivre, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as Glucagon-Like Peptide‑1 Receptor Agonists for Treating DiabetesRam W SabnisACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as GIPR Agonists for Treating Type 2 Diabetes Mellitus and ObesityRam W SabnisPageof 438